Stocks and Investing
Stocks and Investing
Fri, April 30, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, April 29, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tiago Fauth Maintained (APLS) at Hold with Increased Target to $39 on, Apr 29th, 2021
Tiago Fauth of Credit Suisse, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Increased Target from $37 to $39 on, Apr 29th, 2021.
Tiago has made no other calls on APLS in the last 4 months.
There are 2 other peers that have a rating on APLS. Out of the 2 peers that are also analyzing APLS, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tiago
- Madhu Kumar of "Goldman Sachs" Initiated at Strong Buy and Held Target at $130 on, Friday, April 16th, 2021
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $104 on, Friday, January 8th, 2021
Contributing Sources